MADRIGAL PHARMACEUTICALS, INC. (MDGL)

SEC filing

MADRIGAL PHARMACEUTICALS, INC.

MDGL · CIK 1157601

4 · Jan 13, 2026 · FRIEDMAN PAUL A sold 280 shares at $551.24/share ($154.3K); exercised options for 280 shares

FRIEDMAN PAUL A sold 280 shares at $551.24/share ($154.3K); exercised options for 280 shares

FORM 4

xslF345X05/wk-form4_1768340834.xmlSEC.gov

Graphics and non-inline formats (not embedded below).